Smiths Group Plc (LON:SMIN), The Board of Smiths regularly reviews all options for the Group’s businesses to enhance its leadership positions and maximise value for Smiths shareholders. It announced today that it intends to separate Smiths Medical from Smiths Group plc.
This will:
– Enable Smiths to concentrate on growing as an Industrial Technology group, united by shared business characteristics and a common operating model; and
– Free Smiths Medical to deliver on its full potential, capitalising on its leading positions, large programme of new product launches and to exploit value creating opportunities in its rapidly changing market.
Separation planning, which is at an early stage, will be undertaken in parallel with the continued execution of the Group’s overall growth strategy.
We will provide an update on the details of the planned separation with the Group’s interim results in March 2019.
Andy Reynolds Smith, Chief Executive of Smiths, said:
“This is an exciting development for Smiths and Smiths Medical. This planned separation will strengthen both Smiths and Smiths Medical as they each focus on accelerating the execution of their plans and maximising the opportunities in their respective markets.
Following our focus on operational improvements and increased investment, we believe it is now time to prepare the separation of Smiths Medical from the rest of the Group. Smiths Medical is well positioned to capitalise on its leadership positions and the investments made in the business.
Smiths will concentrate on executing on its growth strategy as a global leader in Industrial Technology, driving maximum value for our shareholders.”
